Peter Davoren

Increased intestinal permeability as a risk factor for type 2 diabetes

Amanda J. Cox, Ping Zhang, Donald W. Bowden et al. · Diabetes & Metabolism · 2016 · 133 citations

Intestinal Permeability, Physiology, Diabetes +8

Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non—insulin-dependent diabetes mellitus

Peter Davoren, WilliamH Kelly, F. A. Gries et al. · Metabolism · 1998 · 17 citations

Metabolic Syndrome, Sustained-release Preparation, Diabetes Management +12

Frequency of hand and shoulder symptoms in patients with Type 1 diabetes

Y. R. Raje, G. Cracknell, Peter Davoren · Diabetic Medicine · 2015 · 16 citations

A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes

François Curtin, Bernard Champion, Peter Davoren et al. · Diabetes Obesity and Metabolism · 2020 · 16 citations · Full text

Safe prescribing of metformin in diabetes

Peter Davoren · Australian Prescriber · 2014 · 13 citations · Full text